Patents/Assignees

Pfizer Inc.

150 patents in portfolio

US11866425utility2024
Diacylglycerol Acyl Transferase 2 Inhibitors
0 cites
US11858916utility2024
GLP-1 Receptor Agonists and Uses Thereof
0 cites
US11857622utility2024
Human Cytomegalovirus GB Polypeptide
0 cites
US11845732utility2023
Solid State Forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide and Uses Thereof
0 cites
US11840572utility2023
Therapeutic Antibodies and Their Uses
0 cites
US11833216utility2023
Anti-edb Antibodies and Antibody-drug Conjugates
0 cites
US11820748utility2023
Solid State Forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide and Uses Thereof
0 cites
US11814435utility2023
Therapeutic Antibodies and Their Uses
0 cites
US11802121utility2023
GLP-1 Receptor Agonists and Uses Thereof
0 cites
US11802127utility2023
3,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as MEK Inhibitors
0 cites
US11802156utility2023
Antibodies to Madcam
0 cites
US11779631utility2023
CD47 Blockade Therapy by HDAC Inhibitors
0 cites
US11780853utility2023
Substituted N-pyrimidin-4-yl-3-aminopyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors
0 cites
US11771764utility2023
CD47 Blockade with Radiation Therapy
0 cites
US11773082utility2023
CDK2 Inhibitors
0 cites
US11730800utility2023
Neisseria Meningitidis Compositions and Methods Thereof
0 cites
US11723965utility2023
Glycoconjugation Processes and Compositions
0 cites
US11718603utility2023
CDK2 Inhibitors
0 cites
US11718864utility2023
Cells and Method of Cell Culture
0 cites
US11712480utility2023
Heteroaryl Sulfone-based Conjugation Handles, Methods for Their Preparation, and Their Use in Synthesizing Antibody Drug Conjugates
0 cites

← PreviousPage 6 of 8Next →